诺和诺德Novo Nordisk (NVO) 2014年年度报告「NYSE」.pdf

1、novo nordisk annual report2014CITIES NEED TO FIGHT DIABETES but how?THE STRUGGLE TO LOSE WEIGHT obesity is a major public health issueSTAY FOCUSED,THINK LONG-TERM Novo Nordisks business strategyA CURE FOR TYPE 1 DIABETES dream or potential reality?62014 PERFORMANCE AND 2015 OUTLOOK16BUSINESS STRATEG

2、Y STAY FOCUSED,THINK LONG-TERM20NOVO NORDISK AROUND THE WORLD28THE CHALLENGE OF CHANGING DIABETES34CITIES FIGHTURBAN DIABETESCONTENTSACCOMPLISHMENTS AND RESULTS 2014GOVERNANCE,LEADERSHIP AND SHARESOUR BUSINESSFINANCIAL,SOCIAL AND ENVIRONMENTAL STATEMENTSADDITIONAL INFORMATION16Business strategy stay

3、 focused,think long-term20 Novo Nordisk around the world26 Pipeline overview28The challenge of changing diabetes30Wanted:more treatment options32Type 1 diabetes in search of a cure34 Cities fight urban diabetes36The struggle to lose weight38When blood doesnt clot39Growth matters40The people side of

4、the business42Be aware of the risk1Letter from the Chairman2 Letter from the CEO4Novo Nordisk at a glance62014 performance and 2015 outlook14Performance highlights44Shares and capital structure46Corporate governance49Remuneration52Board of Directors54Executive Management55 Consolidated financial,soc

5、ial and environmental statements105 Financial statements of the parent company109 Managements statement and Auditors reports112Product overview 113More informationTHE STRUGGLE TO LOSE WEIGHT36The Management review,as defined by the Danish Financial Statements Act(FSA),is found on pp 154 and 95.This

6、Annual Report is published in English only.A shorter version,consisting of the Management review and excerpts from the consolidated statements,is available in Danish.In the event of any discrepancies,the English version shall prevail.1In my letter in last years annual report,I expressed the Board of